Posted on August 13, 2018 by Sitemaster
A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: approval, benefit, devices, FDA, HIFU, information, medical, patient, preference, risk | Leave a comment »
Posted on July 5, 2018 by Sitemaster
A new paper from the Emberton-Ahmed group in the UK has reported 5-year follow-up data from a cohort of > 600 patients with clinically significant, localized prostate cancer, all treated with focal forms of high-intensity focused ultrasound (HIFU). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, HIFU, high, high-intensity, intermediate, risk, ultrasound | 7 Comments »
Posted on June 8, 2018 by Sitemaster
A new review article offers us some greater clarity related to the role of targeted, high-intensity focused ultrasound (HIFU) to treat carefully selected areas of the prostate to eliminate primary or index lesions while leaving the remainder of the prostate intact. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ablation, focused, HIFU, high-intensity, partial, targeted, ultrasound | 2 Comments »
Posted on April 30, 2018 by Sitemaster
An interesting article has just been published in the Journal of Urology which helps to provide information (and context) about the quality of data supporting the use of high-intensity focused ultrasound (HIFU) in the treatment of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: choice, effectiveness, focused, HIFU, high-intensity, patient, preference, safety, ultrasound | 6 Comments »
Posted on March 26, 2018 by Sitemaster
According to a media release issued on March 18 by EDAP TMS, the US healthcare insurance firm CIGNA has agreed to cover the use of high-intensity focal ultrasound (HIFU) as a second-line, salvage therapy for men with radiorecurrent prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: focused, HIFU, high-intensity, insurance, salvage, Treatment, ultrasound | Leave a comment »
Posted on September 23, 2017 by Sitemaster
We were recently made aware of a video on Facebook promoting high-intensity focused ultrasound (HIFU) as a treatment for prostate cancer. The video promotes the services of a particular group of physicians who specialize in this form of treatment. They are, of course, entirely entitled to do this. READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focused, HIFU, high-intensity, misleading, promotion, ultraslund | 11 Comments »
Posted on October 5, 2016 by Sitemaster
An article by Julie Appleby of Kaiser Health News, posted yesterday on the STAT health news web site, asks whether high-intensity focused ultrasound (HIFU) is being “over-sold” to prostate cancer patients based on the limited outcome data currently available. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focused, HIFU, high-intensity, ultrasound | 3 Comments »
Posted on October 3, 2016 by Sitemaster
We have long presumed that it would be possible to consider high-intensity focused ultrasound (HIFU) as a form of salvage therapy for men with biochemically recurrent disease after either surgery or radiation therapy. Now there are some data on this concept. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: focused, HIFU, salvage, ultrasound | 3 Comments »
Posted on September 23, 2016 by Sitemaster
Another breathless media release has announced enrollment of the first patient into a Phase II clinical trial of yet another new form of high-intensity, focused ultrasound (HIFU) in men with low-risk and favorable, intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: focal, HIFU, high-intensity, trial, ultrasound | Leave a comment »
Posted on August 11, 2016 by Sitemaster
According to information in the Boston Herald earlier today, researchers at Brigham & Women’s Hospital in Boston (one of the main teaching hospitals associated with Harvard University) are testing a new form of technology to treat localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focused, HIFU, high-intesnisty, trial, ultrasound | Leave a comment »
Posted on April 22, 2016 by Sitemaster
In addition to the French data previously referred to on this site, data from another, much larger cohort of men treated with focal, high-intensity focused ultrasound (focal HIFU) are also to be presented at the upcoming annual meeting of the American Urological Association. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal, hemiablation, HIFU, intermediate risk, outcome, side effect | 4 Comments »
Posted on April 13, 2016 by Sitemaster
A major plenary presentation at the upcoming annual meeting of the American Urological Association (AUA) will provide data from a rather small French trial of high-intensity focused ultrasound (HIFU) in the focal management of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: ablation, focal, hemiablation, HIFU, high-intensity, outcome, ultrasound | Leave a comment »
Posted on March 11, 2016 by Sitemaster
For several years now, the Ahmed/Emberton-led research team in the United Kingdom (UK) has published the majority of the detailed outcomes data from treatment of men with localized prostate cancer using high-intensity focused ultrasound (HIFU). This group has now given us 5-year outcomes on a cohort of > 550 patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: complication, focused, HIFU, high-intensity, outcome, side effect, ultrasound | 13 Comments »
Posted on February 24, 2016 by Sitemaster
A new paper in “the Red Journal” prvides some information about the potential of proton beam radiation therapy (PBRT) as a salvage therapy in men who have failed either cryotherapy or first-line high-intensity focused ultrasound (HIFU) as first-line therapy for localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cryotherapy, HIFU, PBRT, proton, radiation, salvage | 3 Comments »
Posted on February 11, 2016 by Sitemaster
A new report provides data from a prospective, single-center, Phase II trial of high-intensity focused ultrasound (HIFU) in prostate cancer hemiablation as a form of focal therapy. The study was carried out in Belgium. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, focused, hemiablation, HIFU, high-intensity, outcome, Treatment, ultrasound | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 